Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine

References

• SpencerTBiedermanJWilensTNonstimulant treatment of adult attention-deficit/hyperactivity disorderPsychiatr Clin North Am200427237338315064003
   PubMed Web of Science ®Google Scholar
• KooijSJBejerotSBlackwellAEuropean consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHDBMC Psychiatry2010106720815868
   PubMed Web of Science ®Google Scholar
• CarotenutoMEspositoMFDi PasqualeFFDe StefanoSSantamariaFPsychological, cognitive and maternal stress assessment in children with primary ciliary dyskinesiaWorld J Pediatr20139731231724235065
   PubMed Web of Science ®Google Scholar
• EspositoMAntinolfiLFGallaiBFExecutive dysfunction in children affected by obstructive sleep apnea syndrome: an observational studyNeuropsychiatr Dis Treat201391087109423976855
   PubMedGoogle Scholar
• EspositoMGallaiBFParisiLFVisuomotor competencies and primary monosymptomatic nocturnal enuresis in prepubertal aged childrenNeuropsychiatr Dis Treat2013992192623847418
   PubMed Web of Science ®Google Scholar
• EspositoMGallaiBFParisiLFPrimary nocturnal enuresis as a risk factor for sleep disorders: an observational questionnaire-based multicenter studyNeuropsychiatr Dis Treat2013943744323579788
   PubMed Web of Science ®Google Scholar
• EspositoMCarotenutoMIntellectual disabilities and power spectra analysis during sleep: a new perspective on borderline intellectual functioningJ Intellect Disabil Res201458542142923517422
   PubMed Web of Science ®Google Scholar
• EspositoMCarotenutoMFRoccellaMPrimary nocturnal enuresis and learning disabilityMinerva Pediatr20116329910421487372
   PubMed Web of Science ®Google Scholar
• EspositoMCarotenutoMBorderline intellectual functioning and sleep: the role of cyclic alternating patternNeurosci Lett20104852899320813159
   PubMed Web of Science ®Google Scholar
• EspositoMGallaiBRoccellaMAnxiety and depression levels in prepubertal obese children: a case-control studyNeuropsychiatr Dis Treat2014101897190225336955
   PubMed Web of Science ®Google Scholar
• DueckAThomeJFHaesslerFThe role of sleep problems and circadian clock genes in childhood psychiatric disordersJ Neural Transm (Vienna)2012119101097110422669264
   PubMed Web of Science ®Google Scholar
• CabralPAttention deficit disorders: are we barking up the wrong tree?Eur J Paediatr Neurol2006102667716617029
   PubMed Web of Science ®Google Scholar
• KisslingCRetzWFWiemannSA polymorphism at the 3′-untranslated region of the CLOCK gene is associated with adult attention-deficit hyperactivity disorderAm J Med Genet B Neuropsychiatr Genet2008147333333817948273
   PubMed Web of Science ®Google Scholar
• XuXBreenGChenCHuangYWuYAshersonPAssociation study between a polymorphism at the 3′-untranslated region of CLOCK gene and attention deficit hyperactivity disorderBehav Brain Funct201064820704703
   PubMed Web of Science ®Google Scholar
• ModestinoEJWinchesterJA retrospective survey of childhood ADHD symptomatology among adult narcolepticsJ Atten Disord201317757458223548870
   PubMed Web of Science ®Google Scholar
• JaksaPADHD Fact Sheet Available from: https://add.org/adhd-facts/Accessed December 16, 2015
   Google Scholar
• SearightHRBurkeJMRottnekFAdult ADHD: evaluation and treatment in family medicineAm Fam Physician2000629207720862091209211087189
   PubMed Web of Science ®Google Scholar
• The Mayo ClinicDiseases and Conditions: Adult ADHD Available from: http://www.mayoclinic.org/diseases-conditions/adult-adhd/basics/definition/con-20034552?reDate=01102015Accessed December 16, 2015
   Google Scholar
• FayyadJde GraafRKesslerRCross-national prevalence and correlates of adult attention-deficit hyperactivity disorderBr J Psychiatry200719040240917470954
   PubMed Web of Science ®Google Scholar
• KesslerRCAdlerLBarkleyRThe prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey ReplicationAm J Psychiatry2006163471672316585449
   PubMed Web of Science ®Google Scholar
• GoodmanDWThe consequences of attention-deficit/hyperactivity disorder in adultsJ Psychiatr Pract200713531832717890980
   PubMedGoogle Scholar
• KendallTTaylorEPerezATaylorCDiagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidanceBMJ2008337a123918815170
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and PreventionAttention-Deficit/Hyperactivity Disorder (ADHD) Available from: http://www.cdc.gov/ncbddd/adhd/guidelines.htmlAccessed December 16, 2015
   Google Scholar
• National Institute for Health and Care ExcellenceTreatment for attention deficit hyperactivity disorder in adults: Choice of drug treatment Available from: http://goo.gl/emdNXQAccessed December 16, 2015
   Google Scholar
• DodsonWWPharmacotherapy of adult ADHDJ Clin Psychol200561558960615723384
   PubMed Web of Science ®Google Scholar
• JainUHechtmanLWeissMEfficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover studyJ Clin Psychiatry200768226827717335326
   PubMed Web of Science ®Google Scholar
• KolarDKellerAGolfinopoulosMCumynLSyerCHechtmanLTreatment of adults with attention-deficit/hyperactivity disorderNeuropsychiatr Dis Treat20084238940318728745
   PubMedGoogle Scholar
• National Collaborating Centre for Mental HealthAttention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adultsNICE clinical guideline 72 Available from: http://www.ncbi.nlm.nih.gov/books/NBK53652Accessed December 16, 2015
   Google Scholar
• NuttDJFoneKAshersonPEvidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for PsychopharmacologyJ Psychopharmacol2007211104117092962
   PubMed Web of Science ®Google Scholar
• SeixasMWeissMMullerUSystematic review of national and international guidelines on attention-deficit hyperactivity disorderJ Psychopharmacol201226675376521948938
   PubMed Web of Science ®Google Scholar
• ArnoldLEMethylphenidate vs amphetamine: comparative reviewJ Atten Disord200034200211
   Google Scholar
• SpencerTBiedermanJWilensTHardingMO’DonnellDGriffinSPharmacotherapy of attention-deficit hyperactivity disorder across the life cycleJ Am Acad Child Adolesc Psychiatry19963544094328919704
   PubMed Web of Science ®Google Scholar
• ReevesGSchweitzerJPharmacological management of attention-deficit hyperactivity disorderExpert Opin Pharmacother2004561313132015163276
   PubMed Web of Science ®Google Scholar
• VaughanBFegertJKratochvilCJUpdate on atomoxetine in the treatment of attention-deficit/hyperactivity disorderExpert Opin Phar macother2009104669676
   PubMed Web of Science ®Google Scholar
• Ramos-QuirogaJAMontoyaAKutzelniggADeberdtWSobanskiEAttention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelinesCurr Med Res Opin20132991093110423742051
   PubMed Web of Science ®Google Scholar
• HimpelSBanaschewskiTHeiseCARothenbergerAThe safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorderExpert Opin Drug Saf20054231132115794722
   PubMedGoogle Scholar
• SetyawanJHodgkinsPGuerinAComparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysisJ Med Econ201316796297523621503
   PubMedGoogle Scholar
• SetyawanJGuerinAHodgkinsPTreatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medicationsJ Med Econ201316111275128924004347
   PubMedGoogle Scholar
• SetyawanJHodgkinsPGuerinAComparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and adultsJ Med Econ201316101203121523937642
   PubMedGoogle Scholar
• ShawMHodgkinsPCaciHA systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatmentBMC Med2012109922947230
   PubMed Web of Science ®Google Scholar
• SafrenSADuranPYovelIPerlmanCASprichSMedication adherence in psychopharmacologically treated adults with ADHDJ Atten Disord200710325726017242421
   PubMedGoogle Scholar
• GajriaKLuMSikiricaVAdherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature reviewNeuropsychiatr Dis Treat2014101543156925187718
   PubMed Web of Science ®Google Scholar
• BanaschewskiTCoghillDSantoshPLong-acting medications for the hyperkinetic disorders. A systematic review and European treatment guidelineEur Child Adolesc Psychiatry200615847649516680409
   PubMed Web of Science ®Google Scholar
• RetzWRetz-JungingerPThomeJRoslerMPharmacological treatment of adult ADHD in EuropeWorld J Biol Psychiatry201112Suppl 1899421906003
   PubMed Web of Science ®Google Scholar
• RoskellNSSetyawanJZimovetzEAHodgkinsPSystematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetineCurr Med Res Opin20143081673168524627974
   PubMed Web of Science ®Google Scholar
• CoghillDBanaschewskiTLecendreuxMEuropean, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorderEur Neuropsychopharmacol201323101208121823332456
   PubMed Web of Science ®Google Scholar
• ChildressACSalleeFRThe use of lisdexamfetamine dimesylate for the treatment of ADHDExpert Rev Neurother2012121132622243042
   PubMed Web of Science ®Google Scholar
• What place for lisdexamfetamine in children and adolescents with ADHD?Drug Ther Bull2013511011411724113146
   PubMedGoogle Scholar
• QuanHSundararajanVHalfonPCoding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative dataMed Care200543111130113916224307
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)Arlington, VAAmerican Psychiatric Publishing2013
   Google Scholar
• ElixhauserASteinerCHarrisDRCoffeyRMComorbidity measures for use with administrative dataMed Care19983618279431328
   PubMed Web of Science ®Google Scholar
• YeawJBennerJSWaltJGSianSSmithDBComparing adherence and persistence across 6 chronic medication classesJ Manag Care Pharm200915972874019954264
   PubMed Web of Science ®Google Scholar
• Eli Lilly and CompanyStarting Strattera Available from: http://www.trattera.com/adult/starting-strattera.htmlAccessed December 16, 2015
   Google Scholar
• HodgkinsPSasaneRChristensenLErderHHarleyCPersistence, augmentation, and consumption of long-acting medications in ADHD patientsAm J Pharm Benefits20124e149e158
   Google Scholar
• van den BanESouvereinPCSwaabHvan EngelandHEgbertsTCHeerdinkERLess discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the NetherlandsAtten Defic Hyperact Disord20102421322021258431
   PubMedGoogle Scholar
• SchlanderMSchwarzOTrottGEViapianoMBonauerNWho cares for patients with attention-deficit/hyperactivity disorder (ADHD)? Insights from Nordbaden (Germany) on administrative prevalence and physician involvement in health care provisionEur Child Adolesc Psychiatry200716743043817468967
   PubMed Web of Science ®Google Scholar
• UpadhyayaHAdlerLACasasMBaseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetineChild Adolesc Psychiatry Ment Health2013711423648011
   PubMed Web of Science ®Google Scholar
• FridmanMHodgkinsPSKahleJSErderMHPredicted effect size of lisdexamfetamine treatment of attention deficit/hyperactivity disorder (ADHD) in European adults: Estimates based on indirect analysis using a systematic review and meta-regression analysisEur Psychiatry201530452152725725594
   PubMed Web of Science ®Google Scholar
• Ben AmorLSikiricaVCloutierMCombination and switching of stimulants in children and adolescents with attention deficit/hyperactivity disorder in QuebecJ Can Acad Child Adolesc Psychiatry201423315716625320609
   PubMedGoogle Scholar
• LachaineJDeGSikiricaVTreatment patterns, resource use, and economic outcomes associated with atypical antipsychotic prescriptions in children and adolescents with attention-deficit hyperactivity disorder in QuebecCan J Psychiatry2014591159760825565476
   PubMed Web of Science ®Google Scholar
• SikiricaVPliszkaSRBettsKAComparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychoticsJ Manag Care Pharm201218967668923206211
   PubMed Web of Science ®Google Scholar
• SikiricaVPliszkaSRBettsKAImpact of atypical antipsychotic use among adolescents with attention-deficit/hyperactivity disorderAm J Manag Care201420971172125365746
   PubMed Web of Science ®Google Scholar